Net Income

Investors eye Moody's CEO Rob Fauber's upcoming speech for insights on AI strategy, M&A forecasts, and navigating an increasingly complex global economy.

Struggling manufacturer Highway Holdings acquires a 51% stake in Germany's Regent-Feinbau, a bold move to enter high-value markets and build resilient supply chains.

With mixed trial results for its obesity drug and rising costs, Skye Bioscience's upcoming 2025 earnings call is a pivotal moment for investors.

Biotech firm Immunis, Inc. secures a promising drug candidate to treat a debilitating side effect of Parkinson's therapy, offering hope to millions.

Kura Oncology's new AML drug, KOMZIFTI, sees rapid market uptake, strong financials, and an ambitious plan to reshape targeted cancer therapy.

Houston's largest credit union wins its second Gallup award in three years. We explore the strategy connecting happy employees to a thriving bottom line.

Ad-tech giant Teads reports massive revenue growth post-merger, but a $352M impairment and restructuring signal deep integration challenges.

The Geneva Association recognizes Elena Sanz for her exceptional leadership, blending a human-focused strategy with decisive action during recent crises.

Following key acquisitions, the AI firm pivots to a vertically integrated defense powerhouse, forecasting explosive growth backed by a swelling order backlog.

Royal Caribbean and its new ships claim top honors in the 2026 Cruiseline.com awards, revealing how passenger-driven reviews are shaping the industry.

A Chinese firm's win at a top Korean battery expo signals a major shift in manufacturing tech, accelerating the path to cheaper, greener, solid-state batteries.

Irish Continental Group posts a 10.4% revenue surge and record profits, driven by freight, but faces scrutiny over a sharp rise in debt and port issues.

ST's new STM32C5 microcontroller series promises to bring high-end performance and robust security to billions of cost-sensitive smart devices.

A new global survey reveals the crushing mental burden of diabetes, sparking a call for AI-powered tools that promise to restore spontaneity and control.

German defense tech firm RENK Group reports a record €1.37B revenue, fueled by a 24% surge in its defense business amid global geopolitical tensions.

Record sales of its Trio® fertilizer fuel a major financial turnaround, as the company makes significant strides in extracting battery-grade lithium.

The company narrows losses and sells a major asset, betting on experiential attractions like the Balloon Museum to revitalize NYC's Seaport district.

Backed by Nobel-winning science and French state support, Pasqal's move to go public validates the commercial promise of deep quantum technology.

OmniAb reported declining revenue and a wider net loss for 2025, even as it launched its revolutionary OmniUltra platform and its partners' drugs advance.

Despite a tough 2025, Janus International's Q4 profit jump and 2026 growth forecast signal a strategic pivot driven by smart tech and a key acquisition.